Adverum Biotechnologies (ADVM) Competitors $3.38 -0.05 (-1.49%) As of 12:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADVM vs. HRTX, RGNX, VERV, TECX, ORKA, MREO, BNTC, AURA, CYRX, and RNACShould you be buying Adverum Biotechnologies stock or one of its competitors? The main competitors of Adverum Biotechnologies include Heron Therapeutics (HRTX), REGENXBIO (RGNX), Verve Therapeutics (VERV), Tectonic Therapeutic (TECX), Oruka Therapeutics (ORKA), Mereo BioPharma Group (MREO), Benitec Biopharma (BNTC), Aura Biosciences (AURA), Cryoport (CYRX), and Cartesian Therapeutics (RNAC). These companies are all part of the "pharmaceutical products" industry. Adverum Biotechnologies vs. Heron Therapeutics REGENXBIO Verve Therapeutics Tectonic Therapeutic Oruka Therapeutics Mereo BioPharma Group Benitec Biopharma Aura Biosciences Cryoport Cartesian Therapeutics Adverum Biotechnologies (NASDAQ:ADVM) and Heron Therapeutics (NASDAQ:HRTX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends. Which has stronger valuation & earnings, ADVM or HRTX? Heron Therapeutics has higher revenue and earnings than Adverum Biotechnologies. Heron Therapeutics is trading at a lower price-to-earnings ratio than Adverum Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdverum Biotechnologies$1M70.29-$117.17M-$5.99-0.56Heron Therapeutics$144.29M2.05-$110.56M-$0.09-21.57 Is ADVM or HRTX more profitable? Adverum Biotechnologies has a net margin of 0.00% compared to Heron Therapeutics' net margin of -20.31%. Heron Therapeutics' return on equity of 0.00% beat Adverum Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adverum BiotechnologiesN/A -65.14% -40.52% Heron Therapeutics -20.31%N/A -12.72% Do insiders & institutionals believe in ADVM or HRTX? 48.2% of Adverum Biotechnologies shares are held by institutional investors. Comparatively, 80.0% of Heron Therapeutics shares are held by institutional investors. 4.2% of Adverum Biotechnologies shares are held by company insiders. Comparatively, 5.8% of Heron Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend ADVM or HRTX? Adverum Biotechnologies currently has a consensus target price of $27.83, indicating a potential upside of 723.72%. Heron Therapeutics has a consensus target price of $5.67, indicating a potential upside of 191.95%. Given Adverum Biotechnologies' higher possible upside, equities research analysts plainly believe Adverum Biotechnologies is more favorable than Heron Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adverum Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Heron Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, ADVM or HRTX? Adverum Biotechnologies has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Heron Therapeutics has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Does the MarketBeat Community favor ADVM or HRTX? Heron Therapeutics received 299 more outperform votes than Adverum Biotechnologies when rated by MarketBeat users. Likewise, 68.87% of users gave Heron Therapeutics an outperform vote while only 60.20% of users gave Adverum Biotechnologies an outperform vote. CompanyUnderperformOutperformAdverum BiotechnologiesOutperform Votes36960.20% Underperform Votes24439.80% Heron TherapeuticsOutperform Votes66868.87% Underperform Votes30231.13% Does the media favor ADVM or HRTX? In the previous week, Adverum Biotechnologies had 1 more articles in the media than Heron Therapeutics. MarketBeat recorded 6 mentions for Adverum Biotechnologies and 5 mentions for Heron Therapeutics. Heron Therapeutics' average media sentiment score of 1.00 beat Adverum Biotechnologies' score of 0.52 indicating that Heron Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adverum Biotechnologies 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heron Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHeron Therapeutics beats Adverum Biotechnologies on 12 of the 18 factors compared between the two stocks. Remove Ads Get Adverum Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADVM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADVM vs. The Competition Export to ExcelMetricAdverum BiotechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$70.29M$2.89B$5.34B$7.60BDividend YieldN/A1.91%5.11%4.33%P/E Ratio-0.5630.6721.7617.83Price / Sales70.29437.46378.0693.28Price / CashN/A168.6838.1534.64Price / Book0.413.476.414.00Net Income-$117.17M-$72.06M$3.20B$247.23M7 Day Performance-0.62%8.70%6.59%7.42%1 Month Performance-26.70%-17.38%-8.57%-6.15%1 Year Performance-70.69%-29.70%10.11%-0.03% Adverum Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADVMAdverum Biotechnologies3.9507 of 5 stars$3.38-1.5%$27.83+723.7%-70.8%$70.29M$1M-0.56190Earnings ReportNews CoverageGap DownHRTXHeron Therapeutics3.4789 of 5 stars$1.96-6.7%$5.67+189.1%-33.7%$298.57M$144.29M-10.89300News CoveragePositive NewsRGNXREGENXBIO4.7132 of 5 stars$5.93-5.7%$32.78+452.7%-65.0%$297.01M$83.33M-1.18370Positive NewsGap DownVERVVerve Therapeutics2.9429 of 5 stars$3.34-7.7%$20.67+518.8%-45.8%$296.58M$32.33M-1.36110Analyst ForecastOptions VolumeNews CoverageGap UpHigh Trading VolumeTECXTectonic Therapeutic2.807 of 5 stars$15.53-0.6%$77.75+400.6%N/A$289.84MN/A-2.64120Short Interest ↑Positive NewsGap DownORKAOruka Therapeutics2.9139 of 5 stars$7.62-2.7%$39.86+423.1%N/A$285.30MN/A-1.22N/ANews CoveragePositive NewsHigh Trading VolumeMREOMereo BioPharma Group2.1087 of 5 stars$1.83-8.0%$7.71+321.5%-30.1%$283.92M$1M-30.5040Gap DownHigh Trading VolumeBNTCBenitec Biopharma2.1708 of 5 stars$12.02-2.4%$24.43+103.2%+141.3%$281.88M$80,000.00-7.9620Short Interest ↑AURAAura Biosciences1.9679 of 5 stars$5.52+1.7%$22.75+312.1%-27.7%$277.24MN/A-3.1950Short Interest ↑CYRXCryoport2.6669 of 5 stars$5.49+2.8%$11.83+115.5%-67.6%$274.01M$228.39M-1.621,020Gap DownRNACCartesian Therapeutics1.8541 of 5 stars$10.11+1.1%$42.14+316.8%-33.0%$261.92M$38.91M-0.1964 Remove Ads Related Companies and Tools Related Companies HRTX Alternatives RGNX Alternatives VERV Alternatives TECX Alternatives ORKA Alternatives MREO Alternatives BNTC Alternatives AURA Alternatives CYRX Alternatives RNAC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADVM) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adverum Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adverum Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADVM Stock Free ADVM Stock Alerts